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Abstract
The Northern Health Diabetes Hospital Admission Risk Program is a chronic disease management program that
aims to improve the glycemic management of patients with diabetes. The aim of this project was to determine if
there was any relationship between psychological characteristics and glycemic outcome in a diabetes management
program. A prospective study of patients attending the diabetes management program investigated validated
measures of cognition, stage of change, locus of control, self-efficacy, depression and anxiety, and quality of life.
The study investigated 86 type 2 diabetes patients (mean age 59 years, 49% female). Glycemic control (HbA1c) was
measured at baseline and after 12 months in the program. Glycemic control was poor on admission to the service
with a mean HbA1c of 8.9%. The measures of cognition, self-efficacy, locus of control, mental health, and quality of
life were not associated with improvements in HbA1c. Those participants with shorter duration of disease and
more contacts with the service were significantly more likely to experience improvements in HbA1c. Psychometric
data were not predictive of glycemic outcome. Rather, in this chronic disease management program, glycemia
improved more in patients who were seen earlier in their disease course and managed more intensively, regardless
of their psychometric status. (Population Health Management 2012;15:163–167)
Introduction
Type 2 diabetes is now recognized as the fastest growingchronic disease in Australia and other western countries.
The Australian prevalence of diabetes is 7.4%, with an addi-
tional 16.4% of the population having either impaired fasting
glucose or impaired glucose tolerance.1 There are significant
personal and societal costs associatedwith type 2 diabetes.2 In
developed countries, diabetes is a leading cause of cardio-
vascular disease and renal failure, and it is a leading cause of
blindness and nontraumatic lower limb amputations in those
who are older than 60 years of age.3,4
Interventions to improve the health outcomes of people
with type 2 diabetes have increased steadily over the last 10
years. Despite this, the burden of type 2 diabetes continues to
increase in Australia and internationally. Given the magni-
tude of people with diabetes and finite health resources for
treating chronic diseases, there is a pressing need to identify
factors that compromise the effectiveness of current best-
practice diabetes care models.
The Northern Health Diabetes Hospital Admission Risk
Program (HARP) service is a multidisciplinary disease
management service for patients with poorly controlled
diabetes (defined as glycated hemoglobin [HbA1c] > 8.0%
or the presence of diabetes-related complications). HARP
services are funded by the Victorian Department of
Health; the Northern Health Diabetes Service is based in
outer metropolitan Melbourne. The service offers multi-
disciplinary care comprising endocrinology, diabetes ed-
ucation, dietetics, physiotherapy, and podiatry services.
Patients undergo a comprehensive multidisciplinary as-
sessment and an individualized care plan is developed in
consultation with the patient. The service uses an inte-
grated self-management coaching approach to assist cli-
ents in making the behavioral changes necessary to
improve the management of their diabetes.
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Recently, there has been an increasing focus on patient
psychological characteristics and their influence on diabetes
interventions. Following discussions with clinicians from the
HARP service and a review of the literature, it was hy-
pothesized that patients who did not achieve adequate blood
glucose control were more likely to have poor cognition, an
external locus of control, anxiety and/or depression, and
poor self-efficacy to manage their condition.5–15
A previous program evaluation of the Northern Health
Diabetes HARP service demonstrated that more than 20% of
patients did not achieve target glycemic control (HbA1c <
8%) 12 months after program enrolment.16 Identifying those
patients who are less likely to respond early after enrollment
is the first step to offering them an alternative, more effective
management pathway. The aim of this study was to deter-
mine which of these patient characteristics were associated
with glycemic outcome (change in HbA1c) after 12 months.
Methods
A prospective cohort of patients attending the Northern
Health Diabetes HARP service was recruited to the study at
enrollment into the service (April to December 2008) and
followed for 12 months. All new patients were screened for
eligibility for the study. Exclusion criteria were: <18 years of
age, significant intellectual disability, major psychiatric di-
agnosis, or documented dementia or dysphasia. This study
was approved by the Northern Health Human Research
Ethics Committee and informed consent was obtained from
all participants prior to study enrollment.
At enrollment, the research nurse administered the fol-
lowing questionnaires to participants: Assessment of Quality
of Life (AQoL);17,18 Diabetes Empowerment Scale-Short
Form (DES-SF);19,20 Hospital Anxiety and Depression Scale
(HADS);21,22 Diabetes-Specific Locus of Control Ques-
tionnaire;12 Rowland Universal Dementia Assessment Scale
(RUDAS);23 and the Brief Diabetes Readiness to Change
questionnaire.11 If the patient was not fluent in English, a
professional interpreter was used to administer question-
naires. In addition to the questionnaires, the following rou-
tinely collected data were also obtained: demographic
information, HbA1c, diabetes medications and adherence
(upon admission to the service), and the presence of diabetes-
related complications (following the first endocrinology
assessment). At 12 months, HbA1c was obtained from the
service medical record or the participant’s general practitioner,
and the number of contacts with the service was recorded.
Change in HbA1c was assessed using paired t tests. Uni-
variate and multivariate linear regression analyses were
performed to investigate associations between baseline de-
mographic, cognitive, personality, self-efficacy, and mental
health characteristics and change in HbA1c at 12 months.
Only variables with more than 10 positive cases were in-
cluded in the regression analysis to ensure stability of the
models. Co-linearity and linearity assumptions were tested
prior to multivariate analysis. Variables with a P value
of £ 0.25 in univariate analysis were entered into the multi-
variate models.
Results
A total of 196 patients were screened; 5 were ineligible, 48
were unable to be contacted, and 17 declined to participate in
the study. The final study group had 126 participants.
Change in HbA1c after 12 months was obtained for 86 (68%)
of the participants. Table 1 summarizes baseline statistics for
participants with complete HbA1c data (N = 86). Glycemic
control was poor on admission to the service with a mean
HbA1c of 8.9%. The mean HbA1c at 12 months was 8.2
(standard deviation [SD] 1.4). Mean reduction in HbA1c was
0.7% (SD 1.6), (P < 0.0001), and 35% of participants achieved
an improvement in HbA1c of 1% or more. Participants at-
tended the service an average of 8 times; 10% attended fewer
than 4 times.
When compared to the recruited sample of participants
(N = 126), those with follow-up HbA1c measures (N = 86)
were more likely to be female (42% vs. 49%, P = 0.03) and
more likely to have neuropathy (20% vs. 26%, P = 0.03). There
were no other significant differences in any of the baseline
variables measured.
Measures of personality factors, cognition, mental health,
and quality of life also are summarized in Table 1. Study
participants had fair self-reported health status, which rep-
resents a significantly worse status than the general age-
adjusted Australian population based on normative data
(AQoL utility score = 0.83, SD 0.20).18 Anxiety was common,
but few participants were classified as having probable de-
pression (HADS score > 10).
The mean score for the DES-SF indicates that study par-
ticipants had a moderate level of diabetes-related psycho-
social self-efficacy. The locus of control questionnaire
showed that study participants saw their diabetes control as
something that they could individually influence, but that
they also regarded health professionals and family as being
able to strongly influence their diabetes control. Chance was
viewed as a less important influence on their diabetes con-
trol. The readiness-to-change questionnaire indicates that
25% of clients were in the precontemplation and contem-
plation stages and therefore not considered to be ‘‘ready’’ to
change their diabetes management behaviors, while 56%
were in the preparation and action stage and were motivated
to change their behavior to improve their diabetes control.
There were no significant differences between the recruited
sample (N = 126) and those with follow-up HbA1c data
(N = 86) in any baseline questionnaire results.
Factors predictive of improvement in glycemic control
Univariate regression analysis identified duration of dia-
betes, number of service contacts, presence of anxiety
(HADS > 10), and identifying as maintenance phase in the
readiness to change scale as candidate variables for entry
into the multivariate model. Following multivariate analysis,
duration of diabetes (P = 0.07) and number of service con-
tacts (P = 0.03) were associated with change in HbA1c at
12 months. Longer duration of diabetes was associated
with less improvement in HbA1c (coefficient [95% CI] =
- 0.04 [-0.08, 0.00]), while an increasing number of contacts
was associated with greater improvement in HbA1c (coeffi-
cient [95% CI] = 0.10 [0.01, 0.18]).
To ensure participants with adequate glycemic control
(HbA1c < 8%) at baseline were not confounding the results,
the cohort was reanalyzed excluding these patients (N = 29)
and no significant difference was observed using this model
of analysis compared to the original analysis.
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Post hoc analysis was performed to determine the mini-
mum number of contacts required for significant improve-
ment in HbA1c. Number of contacts was dichotomized at
various ‘‘cut points’’ (eg, 3 or more contacts, 4 or more con-
tacts) and these variables were entered into separate linear
regression models to investigate how many contacts were
required for the change in HbA1c to become significant, as
well as the strength of the association. Duration of disease
was controlled for in each of the models. Table 2 summarizes
the results. Participants who attended for 4 or more contacts
were significantly more likely to experience improvements in
HbA1c at 12 months than those who attended 3 or fewer
visits (P = 0.04). The strength of the association grew with
the minimum number of contacts and peaked at 6 or more
contacts.
Discussion
Evaluation of a multidisciplinary diabetes service dem-
onstrated statistically and clinically significant improve-
ments in HbA1c at 12 months. Patients with longer duration
of diabetes were less likely to experience improvement in
glycemic control and those with a higher number of contacts
with the service had greater improvement in glycemic con-
trol. Patients who attended a minimum of 4 or more sessions
were more likely to experience improvement in glycemic
control while those who attended 6 or more times achieved
the greatest improvement in glycemic control.
The HARP service was designed for individuals with poor
glycemic control and diabetes-related vascular complica-
tions; therefore, it targeted individuals with a longer dura-
tion of disease. Aging is known to cause both a decrease in
insulin production and an increase in insulin resistance. The
progressive nature of diabetes means that these individu-
als may require more intensive medical management and
complex medication regimens to achieve optimal glycemic
control.24 This may explain why the number of service con-
tacts and duration of disease were significant predictors of
achieving target HbA1c levels, and suggests that such dia-
betes programs may be more effective earlier in the disease
course, along with multiple (at least 4) clinician sessions.
Table 1. Demographic, Cognitive, Mental Health, and Personality Characteristics of Study Participants
Baseline Characteristics Personality/Cognitive Characteristics Mean (SD)
Mean age, years (standard
deviation [sd])
58.8 (14.0) Rowland Universal Dementia Assessment
Scale (RUDAS)
26.9 (2.1)
Females N (%) 42 (48.8) (range 0–30)
Primary school education only N (%) 47 (56.0) Diabetes empowerment scale-Short form (DES-SF) 3.4 (0.6)
Preferred language N (%) (range 0–5)
English 57 (66.3) Peyrot and Rubin Diabetes Specific Locus of Control
Other 29 (33.7) Internal 28.0 (4.4)
Country of birth N (%) External: Powerful others 24.7 (5.4)
Australia 20 (23.3) External: Chance 18.2 (5.6)
Other 66 (76.7) (range 6–36)
Required an interpreter N (%) 17 (19.8) Assessment of Quality of Life Utility Scores
Type 1 diabetes N (%) 6 (7.0) Total score 0.69 (0.28)
Type 2 diabetes N (%) 79 (91.9) UD1 – Illness 0.33 (0.20)
Duration of diabetes—years (SD) 11.1 (8.5) UD2 - Independent living 0.87 (0.23)
Mean number of contacts 8.1 (4.2) UD3 – Social relationships 0.91 (0.15)
Medications N (%) UD4 – Physical senses 0.93 (0.08)
Oral hypoglycemic 58 (67.4) UD5 - Psychological well-being 0.86 (0.16)
Insulin and oral hypoglycemic 15 (17.4) (range 0.4–1.0) N (%)
Insulin only 13 (15.1) Hospital Anxiety and Depression Scale (HADS)
Medication compliance issues N (%) 47 (54.7) Anxiety case 18 (21.2)
HbA1c N (%) Depression case 6 (7.1)
< 7 7 (8.1) (range 11–21/21)
7–8 22 (25.6) Readiness to change scale N (%)
> 8 57 (66.3) Precontemplation 4 (4.8)
Mean (SD) 8.9 (1.7) Contemplation 17 (20.2)
Diabetes-related complications N (%) Preparation 23 (27.4)
Nephropathy 31 (36.5) Action 24 (28.6)
Microalbiminuria 31 (36.5) Maintenance 16 (19.0)
Neuropathy 22 (25.9)
Cardiovascular disease 37 (43.5) RUDAS cognitive impairment N (%) 4 (4.7)
Stroke 5 (5.9) (range 0–22/30)
Table 2. Significance and Coefficients of Various
‘‘Cut Points’’ of Number of Contacts as Independent
Predictors of Change in HbA1c
Multivariate Linear Regression* Coefficient (95% CI) P
Model 1: 3 or more contacts NS NS
Model 2: 4 or more contacts 1.08 (0.05, 2.11) 0.04
Model 3: 5 or more contacts 0.28 (0.46, 2.10) 0.00
Model 4: 6 or more contacts 1.34 (0.65,2.04) 0.00
Model 5: 7 or more contacts 0.99 (0.29, 1.69) 0.01
Model 6: 8 or more contacts NS NS
*Duration of diabetes was controlled for in all models.
CI, confidence interval; NS, nonsignificant.
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The psychological measures in this study were not asso-
ciated with glycemic control in contrast to findings of other
studies.5,7–11 There are several potential explanations for
these findings.
The prevalence of depression in this sample was relatively
low at 7%. The prevalence of depression in adults with di-
abetes is reported in the literature to be between 11% and
31%, and to be higher in hospital/clinical setting than in
community settings.25 We previously reported the preva-
lence of depression in the outpatient diabetes clinic popula-
tion to be 16%.26 The lower prevalence of depression in this
study cohort may suggest that the cohort is not entirely
representative of a typical diabetes population and the low
prevalence of depression may have made it difficult to
demonstrate a relationship with glycemic outcome.
Some of the questionnaires used may not have been sen-
sitive enough to measure the characteristics of participants in
this study accurately because they were developed and
validated in highly educated English-speaking populations.
For example, both the DES-SF and Diabetes-Specific Locus
of Control questionnaires were developed and validated in
predominantly college-educated populations.12,19,20 In con-
trast, half of this population did not receive any schooling
beyond primary school, and over one third preferred to
speak a language other than English.
The finding that locus of control was not associated with
improvements in glycemic control is consistent with a re-
cently published meta-analysis of 17 studies, which also
concluded that there is no correlation between locus of
control and glycemic outcome.27
This study utilized a series of questionnaires that focus on
evaluation of baseline beliefs (self-efficacy, stages of change,
locus of control) and impairments/health status (depression
and anxiety, cognitive function, quality of life). It did not
assess or capture information relating to behaviors. The
premise of the study was that beliefs and impairments could
influence behaviors, and therefore outcomes. Clearly, there
may have been aspects of behavior change (that were not
measured) that may have influenced outcome (eg, carer
support or access to additional primary health care services).
Importantly, this sample may have been too small to
identify variations in the personality characteristics mea-
sured and the glycemic control outcome. Although there
were no major significant differences in the baseline char-
acteristics of the overall sample (n = 126) and the analysis
sample (n = 86), a 32% loss to follow-up highlights the diffi-
culty with adherence in this population. In addition, 70 pa-
tients who were screened for participation in the study
(n = 196) were not recruited. Although only minimal data
were collected on these participants, we know that there
were no significant differences in age and sex between those
screened and those who consented. There may have been
systematic differences in other baseline characteristics that
could have affected the outcomes of the study.
This study sought to explore associations between per-
sonality characteristics and glycemic outcomes for patients
attending a diabetes service. Further research is required to
develop and validate instruments that measure self-efficacy
in culturally and linguistically diverse populations with poor
health literacy. Longitudinal studies of trends in stages of
change throughout a patient’s progression through treat-
ment should be undertaken to provide more detailed infor-
mation on their capacity to move between stages of change
while undertaking chronic disease self-management pro-
grams. Larger longitudinal cohort studies also are required
to study in detail the personal and environmental factors that
influence an individual’s capacity to modify behavior and
improve glycemic and health outcomes.
The measures of cognition, diabetes self-efficacy, locus of
control, mental health, and quality of life used in this study
were not associated with improvements in glycemic control
at 12 months. Creation of more sensitive psychometric
questionnaires is necessary to profile patients with diabetes,
given the great educational and cultural heterogeneity that
exists in such populations. Importantly, this study identified
that those with longer duration of disease and fewer contacts
with the service were significantly less likely achieve optimal
glycemic control, suggesting that chronic disease manage-
ment programs may be more effective if they target partici-
pants earlier in their disease and provide a more intensive
intervention.
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